Claypoole Robert E 4
4 · Bioventus Inc. · Filed Jan 12, 2024
Insider Transaction Report
Form 4
Claypoole Robert E
DirectorPresident and CEO
Transactions
- Award
Restricted Stock Units
2024-01-11+375,000→ 375,000 total→ Class A Common Stock (375,000 underlying) - Award
Stock Option (Right to Buy)
2024-01-11+850,000→ 850,000 totalExercise: $4.89Exp: 2034-01-11→ Class A Common Stock (850,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The restricted stock units and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.